LEADER 02031oam  2200601I  450 
001 9910709845103321
005 20180803083137.0
035   $a(CKB)5470000002473806
035   $a(OCoLC)1032263275
035   $a(EXLCZ)995470000002473806
100   $a20180424d2018      ua             0
101 0 $aeng
135   $aurcn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aIllicit opioids $ewhile greater attention given to combating synthetic opioids, agencies need to better assess their efforts : report to congressional requesters
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2018.
215   $a1 online resource (iii, 88 pages) $ccolor illustrations
300   $a"March 2018."
300   $a"GAO-18-205."
320   $aIncludes bibliographical references.
517   $aIllicit opioids 
606   $aDrug control$xInternational cooperation$xEvaluation
606   $aOpioid abuse$zUnited States$xPrevention$xEvaluation
606   $aMedication abuse$zUnited States$xPrevention$xEvaluation
606   $aSynthetic drugs
606   $aDrug control$zUnited States$xEvaluation
606   $aDrug control$xEvaluation$2fast
606   $aManagement$xEvaluation$2fast
606   $aOpioids$2fast
606   $aSynthetic drugs$2fast
607   $aUnited States$2fast
615  0$aDrug control$xInternational cooperation$xEvaluation.
615  0$aOpioid abuse$xPrevention$xEvaluation.
615  0$aMedication abuse$xPrevention$xEvaluation.
615  0$aSynthetic drugs.
615  0$aDrug control$xEvaluation.
615  7$aDrug control$xEvaluation.
615  7$aManagement$xEvaluation.
615  7$aOpioids.
615  7$aSynthetic drugs.
801  0$bDID
801  1$bDID
801  2$bXFF
801  2$bOCLCF
801  2$bOCLCQ
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910709845103321
996   $aIllicit opioids$93449340
997   $aUNINA